Palvella Therapeutics Granted Additional U.S. Patent for QTORIN™ Rapamycin for the Treatment of – Bluefield Daily Telegraph

22nd April 2025

Palvella Therapeutics Granted Additional U.S. Patent for QTORIN™ Rapamycin for the Treatment of Bluefield Daily Telegraph